Stammdaten
Dyne Therapeutics, Inc., ein Unternehmen im Bereich Muskelerkrankungen, operiert als Biotechnologie-Unternehmen, das sich auf die Entwicklung von Therapeutika für genetisch bedingte Muskelerkrankungen in den Vereinigten Staaten konzentriert. Es entwickelt verschiedene Programme für myotone Dystrophie Typ 1, Duchenne-Muskeldystrophie und fazioscapulohumeale Dystrophie sowie seltene Skelettmuskel-, Herz- und metabolische Muskelerkrankungen unter Verwendung seiner FORCE-Plattform, die krankheitsmodifizierende Therapeutika bereitstellt. Das Unternehmen wurde 2017 gegründet und hat seinen Hauptsitz in Waltham, Massachusetts. KI
Unternehmen & Branche
| Name | Dyne Therapeutics, Inc. |
|---|---|
| Ticker | DYN |
| CIK | 0001818794 |
| Börse | Nasdaq |
| Sektor | Gesundheit |
| Industrie | Biotechnologie (Forschung) |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 26818M108 |
|---|---|
| ISIN | US26818M1080 |
| Typ | Common Stock |
| Marktkapitalisierung | 4,03 Mrd. USD |
| Beta | 1,06 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 1560 TRAPELO ROAD, 02451 WALTHAM, MA |
| Telefon | (781) 786-8230 |
| EIN (IRS) | 36-4883909 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
Bewertung
| KBV (P/B) | 4,15 vs. 1,67 (2021) ▲ |
|---|---|
| FCF-Rendite | -10,0 % vs. -20,1 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -39,1 % vs. -37,2 % (2021) ▼ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 1,67 | 2,56 | 8,96 | 3,83 | 3,32 | 4,66 | |
| FCF-Rendite | -20,1 % | -24,3 % | -23,1 % | -12,2 % | -12,6 % | -11,0 % | |
| Qualität & Bilanz | |||||||
| ROIC | -37,2 % | -59,4 % | -198,8 % | -48,5 % | -39,1 % | -43,7 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
DYN
Dyne Therapeutics, Inc.
Effektiv
Neutral
Handelsvolumen
Mittel
Insider
0,0
Keine Insider-Käufe
Institutionell
35,8
36 neu, 97 erhöht, -343316K $ netto
Aktivist
24,1
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 20.55 | +26.0 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 18.94 | +36.7 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 23.43 | EMA50: 21.51 | |
| MACD-Histogramm | Bullisch | 10 % | 0.061 | Bullisch | |
| RSI(14) | Neutral | 10 % | 69.9 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 92.8 | Überkauft | |
| ADX(14)+DI | Bullisch | 10 % | 31.1 | +DI: 29.2 / −DI: 15.8 | |
| Z-Score(60) | Bärisch | 5 % | 2.09 | Extrem überkauft | |
| 52W-Position | Bullisch | 5 % | 100.0 % | Hoch 25.90 / Tief 9.20 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 108.7 % | Upper 25.57 / Mid 23.67 / Lower 21.78 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.1427 | R²=0.80 / annualisiert +178.6 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-07-27 | Kersten Dirk | Director | Open Market Sale | -5.388 | 26,04 | -140.318,61 | -16,2% | |
| 2026-07-27 | Kersten Dirk | Director | Open Market Sale | -256.072 | 25,50 | -6.530.450,57 | -752,0% | |
| 2026-07-07 | Rhodes Jason P | Director | Open Market Sale | -62.543 | 23,17 | -1.449.121,31 | -166,9% | |
| 2026-07-07 | Rhodes Jason P | Director | Open Market Sale | -49.193 | 23,17 | -1.139.801,81 | -131,2% | |
| 2026-07-07 | Rhodes Jason P | Director | Open Market Sale | -29.587 | 23,62 | -698.844,94 | -80,5% | |
| 2026-07-07 | Rhodes Jason P | Director | Open Market Sale | -14.844 | 23,62 | -350.615,28 | -40,4% | |
| 2026-07-07 | Rhodes Jason P | Director | Open Market Sale | -5.000 | 23,61 | -118.050,00 | -13,6% | |
| 2026-07-07 | Rhodes Jason P | Director | Open Market Sale | -11.665 | 23,62 | -275.527,30 | -31,7% | |
| 2026-07-07 | Rhodes Jason P | Director | Open Market Sale | -124.379 | 23,17 | -2.881.861,43 | -331,9% | |
| 2026-07-06 | Rhodes Jason P | Director | Open Market Sale | -127.182 | 22,79 | -2.898.477,78 | -333,8% | |
| 2026-07-06 | Rhodes Jason P | Director | Open Market Sale | -253.039 | 22,79 | -5.766.758,81 | -664,1% | |
| 2026-07-06 | Rhodes Jason P | Director | Open Market Sale | -100.019 | 22,79 | -2.279.433,01 | -262,5% | |
| 2026-06-29 | Rhodes Jason P | Director | Open Market Sale | -51.756 | 21,14 | -1.094.121,84 | -126,0% | |
| 2026-06-29 | Rhodes Jason P | Director | Open Market Sale | -102.969 | 21,14 | -2.176.764,66 | -250,7% | |
| 2026-06-29 | Rhodes Jason P | Director | Open Market Sale | -40.702 | 21,14 | -860.440,28 | -99,1% | |
| 2026-06-26 | Rhodes Jason P | Director | Open Market Sale | -81.903 | 21,28 | -1.742.895,84 | -200,7% | |
| 2026-06-26 | Rhodes Jason P | Director | Open Market Sale | -162.954 | 21,28 | -3.467.661,12 | -399,3% | |
| 2026-06-26 | Rhodes Jason P | Director | Open Market Sale | -64.411 | 21,28 | -1.370.666,08 | -157,8% | |
| 2026-06-25 | Rhodes Jason P | Director | Open Market Sale | -6.382 | 21,10 | -134.660,20 | -15,5% | |
| 2026-06-25 | Lucera Erick | Officer, Chief Financial Officer | Open Market Sale | -2.362 | 20,37 | -48.113,94 | -5,5% | |
| 2026-06-25 | Rhodes Jason P | Director | Open Market Sale | -12.699 | 21,10 | -267.948,90 | -30,9% | |
| 2026-06-25 | Rhodes Jason P | Director | Open Market Sale | -5.019 | 21,10 | -105.900,90 | -12,2% | |
| 2026-06-24 | Rhodes Jason P | Director | Open Market Sale | -25.397 | 21,02 | -533.844,94 | -61,5% | |
| 2026-06-24 | Rhodes Jason P | Director | Open Market Sale | -50.530 | 21,02 | -1.062.140,60 | -122,3% | |
| 2026-06-24 | Rhodes Jason P | Director | Open Market Sale | -19.973 | 21,02 | -419.832,46 | -48,3% | |
| 2026-06-23 | Rhodes Jason P | Director | Open Market Sale | -30.774 | 21,13 | -650.254,62 | -74,9% | |
| 2026-06-23 | Rhodes Jason P | Director | Open Market Sale | -77.855 | 21,13 | -1.645.076,15 | -189,4% | |
| 2026-06-23 | Rhodes Jason P | Director | Open Market Sale | -39.131 | 21,13 | -826.838,03 | -95,2% | |
| 2026-06-23 | Kersten Dirk | Director | Open Market Sale | -71.629 | 21,04 | -1.506.766,16 | -173,5% | |
| 2026-06-23 | Kersten Dirk | Director | Open Market Sale | -1.657 | 21,47 | -35.582,75 | -4,1% | |
| 2026-06-22 | Kersten Dirk | Director | Open Market Sale | -190.676 | 20,57 | -3.922.262,52 | -451,7% | |
| 2026-06-18 | Kersten Dirk | Director | Open Market Sale | -46.901 | 20,07 | -941.373,42 | -108,4% | |
| 2026-06-17 | Kersten Dirk | Director | Open Market Sale | -37.454 | 20,14 | -754.316,07 | -86,9% | |
| 2026-06-16 | Cox John | Director, Officer, CEO & President | Open Market Sale | -2.683 | 18,33 | -49.179,39 | -5,7% | |
| 2026-06-16 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -887 | 18,33 | -16.258,71 | -1,9% | |
| 2026-06-16 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -145 | 18,33 | -2.657,85 | -0,3% | |
| 2026-06-08 | Posner Brian S | Director | Open Market Purchase | 2.000 | 16,94 | 33.880,00 | +3,9% | |
| 2026-06-03 | Posner Brian S | Director | Open Market Purchase | 2.500 | 17,48 | 43.700,00 | +5,0% | |
| 2026-05-26 | Posner Brian S | Director | Open Market Purchase | 2.000 | 18,21 | 36.420,00 | +4,2% | |
| 2026-05-20 | Posner Brian S | Director | Open Market Purchase | 2.500 | 17,12 | 42.800,00 | +4,9% | |
| 2026-05-13 | Cox John | Director, Officer, CEO & President | Open Market Sale | -3.311 | 18,36 | -60.789,96 | -7,0% | |
| 2026-05-13 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -228 | 18,36 | -4.186,08 | -0,5% | |
| 2026-05-13 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -1.564 | 18,36 | -28.715,04 | -3,3% | |
| 2026-05-13 | Lucera Erick | Officer, Chief Financial Officer | Open Market Sale | -1.448 | 18,36 | -26.585,28 | -3,1% | |
| 2026-05-06 | Rhodes Jason P | Director | Open Market Sale | -17.244 | 18,18 | -313.495,92 | -36,1% | |
| 2026-05-06 | Rhodes Jason P | Director | Open Market Sale | -43.621 | 18,18 | -793.029,78 | -91,3% | |
| 2026-05-06 | Rhodes Jason P | Director | Open Market Sale | -21.926 | 18,18 | -398.614,68 | -45,9% | |
| 2026-05-06 | Rhodes Jason P | Director | Open Market Sale | -428 | 18,18 | -7.781,04 | -0,9% | |
| 2026-05-05 | Rhodes Jason P | Director | Open Market Sale | -2.403 | 18,03 | -43.326,09 | -5,0% | |
| 2026-05-05 | Rhodes Jason P | Director | Open Market Sale | -6.081 | 18,03 | -109.640,43 | -12,6% | |
| 2026-05-05 | Rhodes Jason P | Director | Open Market Sale | -3.056 | 18,03 | -55.099,68 | -6,3% | |
| 2026-05-05 | Rhodes Jason P | Director | Open Market Sale | -60 | 18,03 | -1.081,80 | -0,1% | |
| 2026-05-04 | Rhodes Jason P | Director | Open Market Sale | -3.136 | 18,00 | -56.448,00 | -6,5% | |
| 2026-05-04 | Rhodes Jason P | Director | Open Market Sale | -6.241 | 18,00 | -112.338,00 | -12,9% | |
| 2026-05-04 | Rhodes Jason P | Director | Open Market Sale | -61 | 18,00 | -1.098,00 | -0,1% | |
| 2026-05-04 | Rhodes Jason P | Director | Open Market Sale | -2.466 | 18,00 | -44.388,00 | -5,1% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -1.170 | 18,38 | -21.504,60 | -2,5% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -1 | 19,00 | -19,00 | 0,0% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -21 | 19,00 | -399,00 | 0,0% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -26 | 19,00 | -494,00 | -0,1% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -52 | 19,00 | -988,00 | -0,1% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -47.082 | 18,38 | -865.367,16 | -99,6% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -59.870 | 18,38 | -1.100.410,60 | -126,7% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -119.115 | 18,38 | -2.189.333,70 | -252,1% | |
| 2026-04-27 | Rhodes Jason P | Director | Open Market Sale | -894 | 18,15 | -16.226,10 | -1,9% | |
| 2026-04-27 | Rhodes Jason P | Director | Open Market Sale | -45.709 | 18,15 | -829.618,35 | -95,5% | |
| 2026-04-27 | Rhodes Jason P | Director | Open Market Sale | -90.943 | 18,15 | -1.650.615,45 | -190,1% | |
| 2026-04-27 | Rhodes Jason P | Director | Open Market Sale | -35.947 | 18,15 | -652.438,05 | -75,1% | |
| 2026-04-24 | Rhodes Jason P | Director | Open Market Sale | -28.583 | 18,48 | -528.213,84 | -60,8% | |
| 2026-04-24 | Rhodes Jason P | Director | Open Market Sale | -72.310 | 18,48 | -1.336.288,80 | -153,9% | |
| 2026-04-24 | Rhodes Jason P | Director | Open Market Sale | -36.345 | 18,48 | -671.655,60 | -77,3% | |
| 2026-04-24 | Rhodes Jason P | Director | Open Market Sale | -710 | 18,48 | -13.120,80 | -1,5% | |
| 2026-04-23 | Rhodes Jason P | Director | Open Market Sale | -15.148 | 19,19 | -290.690,12 | -33,5% | |
| 2026-04-23 | Rhodes Jason P | Director | Open Market Sale | -38.322 | 19,19 | -735.399,18 | -84,7% | |
| 2026-04-23 | Rhodes Jason P | Director | Open Market Sale | -19.261 | 19,19 | -369.618,59 | -42,6% | |
| 2026-04-23 | Rhodes Jason P | Director | Open Market Sale | -377 | 19,19 | -7.234,63 | -0,8% | |
| 2026-04-22 | Rhodes Jason P | Director | Open Market Sale | -75.866 | 19,68 | -1.493.042,88 | -171,9% | |
| 2026-04-22 | Rhodes Jason P | Director | Open Market Sale | -1.485 | 19,68 | -29.224,80 | -3,4% | |
| 2026-04-22 | Kersten Dirk | Director | Open Market Sale | -2.652 | 20,00 | -53.049,28 | -6,1% | |
| 2026-04-22 | Rhodes Jason P | Director | Open Market Sale | -150.942 | 19,68 | -2.970.538,56 | -342,1% | |
| 2026-04-22 | Rhodes Jason P | Director | Open Market Sale | -59.663 | 19,68 | -1.174.167,84 | -135,2% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -605 | 20,05 | -12.130,25 | -1,4% | |
| 2026-04-21 | Kersten Dirk | Director | Open Market Sale | -8.300 | 20,01 | -166.120,35 | -19,1% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -142.253 | 19,51 | -2.775.356,03 | -319,6% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -71.499 | 19,51 | -1.394.945,49 | -160,6% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -56.228 | 19,51 | -1.097.008,28 | -126,3% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -1.530 | 20,05 | -30.676,50 | -3,5% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -1.398 | 19,51 | -27.274,98 | -3,1% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -769 | 20,05 | -15.418,45 | -1,8% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -15 | 20,05 | -300,75 | 0,0% | |
| 2026-04-20 | Rhodes Jason P | Director | Open Market Sale | -142.604 | 20,06 | -2.860.636,24 | -329,4% | |
| 2026-04-20 | Rhodes Jason P | Director | Open Market Sale | -71.676 | 20,06 | -1.437.820,56 | -165,6% | |
| 2026-04-20 | Rhodes Jason P | Director | Open Market Sale | -56.368 | 20,06 | -1.130.742,08 | -130,2% | |
| 2026-04-20 | Rhodes Jason P | Director | Open Market Sale | -1.401 | 20,06 | -28.104,06 | -3,2% | |
| 2026-04-20 | Kersten Dirk | Director | Open Market Sale | -125.274 | 20,07 | -2.513.898,41 | -289,5% | |
| 2026-04-17 | Kersten Dirk | Director | Open Market Sale | -211.974 | 20,29 | -4.301.291,62 | -495,3% | |
| 2026-04-16 | Kersten Dirk | Director | Open Market Sale | -11.116 | 21,10 | -234.590,95 | -27,0% | |
| 2026-04-16 | Kersten Dirk | Director | Open Market Sale | -6.657 | 20,06 | -133.522,78 | -15,4% | |
| 2026-04-15 | Kersten Dirk | Director | Open Market Sale | -81.840 | 20,27 | -1.659.044,11 | -191,0% | |
| 2026-04-01 | Lucera Erick | Officer, Chief Financial Officer | Open Market Sale | -5.727 | 18,64 | -106.751,28 | -12,3% | |
| 2026-03-30 | Posner Brian S | Director | Open Market Purchase | 2.000 | 17,08 | 34.160,00 | +3,9% | |
| 2026-03-11 | Posner Brian S | Director | Open Market Purchase | 2.000 | 19,35 | 38.700,00 | +4,5% | |
| 2026-03-11 | Kersten Dirk | Director | Open Market Sale | -129.672 | 19,52 | -2.530.562,05 | -291,4% | |
| 2026-03-10 | Kersten Dirk | Director | Open Market Sale | -219.758 | 19,33 | -4.246.823,35 | -489,0% | |
| 2026-03-10 | Kersten Dirk | Director | Open Market Sale | -281.858 | 19,80 | -5.580.816,59 | -642,6% | |
| 2026-03-10 | Kersten Dirk | Director | Open Market Sale | -9.482 | 18,21 | -172.687,13 | -19,9% | |
| 2026-03-09 | Kersten Dirk | Director | Open Market Sale | -177.690 | 17,72 | -3.148.986,64 | -362,6% | |
| 2026-03-06 | Posner Brian S | Director | Open Market Purchase | 3.000 | 15,06 | 45.180,00 | +5,2% | |
| 2026-03-05 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -148 | 14,90 | -2.205,20 | -0,3% | |
| 2026-03-05 | Cox John | Director, Officer, CEO & President | Open Market Sale | -2.732 | 14,90 | -40.706,80 | -4,7% | |
| 2026-03-05 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -904 | 14,90 | -13.469,60 | -1,6% | |
| 2025-12-05 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -144 | 20,72 | -2.983,68 | -0,3% | |
| 2025-12-05 | Cox John | Director, Officer, CEO & President | Open Market Sale | -2.662 | 20,72 | -55.156,64 | -6,4% | |
| 2025-12-05 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -880 | 20,72 | -18.233,60 | -2,1% | |
| 2025-09-05 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -873 | 13,41 | -11.706,93 | -1,3% | |
| 2025-09-05 | Cox John | Director, Officer, CEO & President | Open Market Sale | -2.640 | 13,41 | -35.402,40 | -4,1% | |
| 2025-09-05 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -144 | 13,41 | -1.931,04 | -0,2% | |
| 2025-09-04 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -3.552 | 13,27 | -47.135,04 | -5,4% | |
| 2025-09-04 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -894 | 13,27 | -11.863,38 | -1,4% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 3189 von typischerweise 8405 Fonds (38 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Janus Henderson Group Ltd. | 13.647.376 | 0 | 13.647.376 | 247.426.927 | Neu | +100,0% | |
| BlackRock, Inc. | 11.699.870 | 0 | 11.699.870 | 212.118.644 | Neu | +100,0% | |
| Atlas Venture Life Science Advisors, LLC | 9.130.465 | 0 | 9.130.465 | 165.535.330 | Neu | +100,0% | |
| FMR LLC | 8.908.980 | 0 | 8.908.980 | 161.519.805 | Neu | +100,0% | |
| Orbis Allan Gray Ltd | 6.762.231 | 0 | 6.762.231 | 122.599.248 | Neu | +100,0% | |
| STATE STREET CORP | 6.653.746 | 0 | 6.653.746 | 120.632.415 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.405.069 | 0 | 6.405.069 | 116.123.901 | Neu | +100,0% | |
| PERCEPTIVE ADVISORS LLC | 4.668.839 | 0 | 4.668.839 | 84.646.051 | Neu | +100,0% | |
| FCPM III SERVICES B.V. | 4.644.386 | 0 | 4.644.386 | 84.202.718 | Neu | +100,0% | |
| TCG Crossover Management, LLC | 4.615.144 | 0 | 4.615.144 | 83.672.561 | Neu | +100,0% | |
| Vestal Point Capital, LP | 4.000.000 | 0 | 4.000.000 | 72.520.000 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3.504.114 | 0 | 3.504.114 | 63.542.557 | Neu | +100,0% | |
| ARMISTICE CAPITAL, LLC | 3.175.110 | 0 | 3.175.110 | 57.564.744 | Neu | +100,0% | |
| Frazier Life Sciences Management, L.P. | 3.153.082 | 0 | 3.153.082 | 57.165.377 | Neu | +100,0% | |
| ORBIMED ADVISORS LLC | 2.917.884 | 0 | 2.917.884 | 52.901.237 | Neu | +100,0% | |
| Siren, L.L.C. | 2.229.125 | 0 | 2.229.125 | 40.414.036 | Neu | +100,0% | |
| Venrock Adviser, LLC | 2.173.913 | 0 | 2.173.913 | 39.413.043 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 2.009.082 | 0 | 2.009.082 | 36.424.648 | Neu | +100,0% | |
| Deep Track Capital, LP | 2.000.000 | 0 | 2.000.000 | 36.260.000 | Neu | +100,0% | |
| SAMLYN CAPITAL, LLC | 1.922.543 | 0 | 1.922.543 | 34.855.705 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1.723.116 | 0 | 1.723.116 | 31.240.093 | Neu | +100,0% | |
| BRAIDWELL LP | 1.681.998 | 0 | 1.681.998 | 30.494.624 | Neu | +100,0% | |
| Palo Alto Investors LP | 1.652.972 | 0 | 1.652.972 | 29.968.382 | Neu | +100,0% | |
| Sofinnova Investments, Inc. | 1.633.897 | 0 | 1.633.897 | 29.622.553 | Neu | +100,0% | |
| Vivo Capital, LLC | 1.557.466 | 0 | 1.557.466 | 28.236.859 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 1.443.313 | 0 | 1.443.313 | 26.167.264 | Neu | +100,0% | |
| Aberdeen Group plc | 1.430.384 | 0 | 1.430.384 | 25.932.862 | Neu | +100,0% | |
| MPM BioImpact LLC | 1.408.152 | 0 | 1.408.152 | 25.529.796 | Neu | +100,0% | |
| Logos Global Management LP | 1.400.000 | 0 | 1.400.000 | 25.382.000 | Neu | +100,0% | |
| Fiera Capital Corp | 1.380.620 | 0 | 1.380.620 | 25.030.641 | Neu | +100,0% | |
| Polar Capital Holdings Plc | 1.359.169 | 0 | 1.359.169 | 24.641.734 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1.198.838 | 0 | 1.198.838 | 21.734.932 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.158.390 | 0 | 1.158.390 | 21.001.611 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.000.000 | 0 | 1.000.000 | 18.130.000 | Neu | +100,0% | |
| Rock Springs Capital Management LP | 972.198 | 0 | 972.198 | 17.625.950 | Neu | +100,0% | |
| Saturn V Capital Management LP | 966.609 | 0 | 966.609 | 17.524.621 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 951.589 | 0 | 951.589 | 17.244.372 | Neu | +100,0% | |
| MORGAN STANLEY | 929.003 | 0 | 929.003 | 16.842.827 | Neu | +100,0% | |
| Squarepoint Ops LLC | 834.176 | 0 | 834.176 | 15.123.611 | Neu | +100,0% | |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 821.849 | 0 | 821.849 | 14.900.122 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 813.449 | 0 | 813.449 | 14.747.830 | Neu | +100,0% | |
| Nuveen, LLC | 718.333 | 0 | 718.333 | 13.023.378 | Neu | +100,0% | |
| ArrowMark Colorado Holdings LLC | 673.949 | 0 | 673.949 | 12.218.695 | Neu | +100,0% | |
| Artisan Partners Limited Partnership | 619.457 | 0 | 619.457 | 11.230.755 | Neu | +100,0% | |
| WASATCH ADVISORS LP | 443.668 | 443.668 | 0 | 9.853.866 | Unverändert | 0,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 533.600 | 0 | 533.600 | 9.674.168 | Neu | +100,0% | |
| TD ASSET MANAGEMENT INC | 529.312 | 0 | 529.312 | 9.596.427 | Neu | +100,0% | |
| STEMPOINT CAPITAL LP | 506.075 | 0 | 506.075 | 9.175.140 | Neu | +100,0% | |
| Ensign Peak Advisors, Inc | 496.590 | 0 | 496.590 | 9.003.177 | Neu | +100,0% | |
| University of Wisconsin Foundation | 484.745 | 0 | 484.745 | 8.788.427 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 3189 von typischerweise 8405 Fonds (38 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 443.668 | 443.668 | 0,0% | 9.853.866 | 26,94 | 100 % | 16 Q |
| NEW YORK STATE COMMON RETIREMENT FUND | 355.953 | 333.497 | +6,7% | 7.905.716 | 21,61 | 100 % | 17 Q |
| ALPS ADVISORS INC | 167.082 | 0 | +100,0% | 3.710.891 | 10,15 | 100 % | 1 Q |
| Y-Intercept (Hong Kong) Ltd | 156.203 | 65.158 | +139,7% | 3.469.269 | 9,49 | 100 % | 7 Q |
| AXXCESS WEALTH MANAGEMENT, LLC | 155.270 | 0 | +100,0% | 3.448.547 | 9,43 | 0 % | 2 Q |
| Darwin Wealth Management, LLC | 155.270 | 154.862 | +0,3% | 3.448.546 | 9,43 | 0 % | 7 Q |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | 87.069 | 0 | +100,0% | 1.933.798 | 5,29 | 0 % | 2 Q |
| Police & Firemen's Retirement System of New Jersey | 40.235 | 36.304 | +10,8% | 893.619 | 2,44 | 100 % | 7 Q |
| China Universal Asset Management Co., Ltd. | 26.310 | 29.219 | -10,0% | 584.345 | 1,60 | 100 % | 16 Q |
| PSP Research LLC | 20.000 | 20.000 | 0,0% | 444.200 | 1,21 | 0 % | 3 Q |
| Z3 Capital Partners, LLC | 18.925 | 19.125 | -1,0% | 420.324 | 1,15 | 0 % | 3 Q |
| Mirae Asset Global Investments Co., Ltd. | 7.393 | 8.588 | -13,9% | 164.199 | 0,45 | 100 % | 16 Q |
| IFP Advisors, Inc | 3.756 | 3.766 | -0,3% | 83.421 | 0,23 | 100 % | 6 Q |
| Hilton Head Capital Partners, LLC | 3.420 | 1.446 | +136,5% | 75.958 | 0,21 | 0 % | 2 Q |
| Sterling Capital Management LLC | 1.960 | 3.281 | -40,3% | 43.532 | 0,12 | 0 % | 8 Q |
| GAMMA Investing LLC | 1.153 | 1.049 | +9,9% | 25.608 | 0,07 | 100 % | 11 Q |
| Versant Capital Management, Inc | 859 | 859 | 0,0% | 19.078 | 0,05 | 100 % | 6 Q |
| SIGNATUREFD, LLC | 420 | 278 | +51,1% | 9.328 | 0,03 | 0 % | 16 Q |
| FIRST HORIZON CORP | 360 | 409 | -12,0% | 7.996 | 0,02 | 21 % | 4 Q |
| WHITTIER TRUST CO OF NEVADA INC | 263 | 150 | +75,3% | 6.267 | 0,02 | 100 % | 2 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 34 | 1,7 | 37 |
| 31.03.2026 | ✓ | 226 | 214,7 | 3.277 |
| 31.12.2025 | ✓ | 232 | 185,3 | 3.162 |
| 30.09.2025 | ✓ | 205 | 161,8 | 1.989 |
| 30.06.2025 | ✓ | 194 | 130,0 | 1.184 |
| 31.03.2025 | ✓ | 201 | 131,8 | 1.343 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| Fiera Capital Corp | 1.380.620 | 25.030.641 |
| Man Group plc | 95.682 | 1.734.714 |
| MOORE CAPITAL MANAGEMENT, LP | 78.765 | 1.428.009 |
| ENVESTNET ASSET MANAGEMENT INC | 68.393 | 1.239.965 |
| Blackstone Inc. | 57.107 | 1.035.350 |
| FIFTH THIRD BANCORP | 54.229 | 983.170 |
| MANGROVE PARTNERS IM, LLC | 47.927 | 868.917 |
| ASSETMARK, INC | 31.062 | 563.154 |
| Orion Porfolio Solutions, LLC | 27.048 | 490.380 |
| Atom Investors LP | 24.078 | 436.534 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 30.785.801 | 13.245.712 | +75.5 % | 558.147 |
| Vestal Point Capital, LP | 4.000.000 | 3.880.000 | +3233.3 % | 72.520.000 |
| FMR LLC | 8.908.980 | 2.339.059 | +35.6 % | 161.519.805 |
| Orbis Allan Gray Ltd | 6.762.231 | 1.960.303 | +40.8 % | 122.599.248 |
| PERCEPTIVE ADVISORS LLC | 4.668.839 | 1.189.895 | +34.2 % | 84.646.051 |
| DIMENSIONAL FUND ADVISORS LP | 951.589 | 853.515 | +870.3 % | 17.244.372 |
| ORBIMED ADVISORS LLC | 2.917.884 | 715.700 | +32.5 % | 52.901.237 |
| Squarepoint Ops LLC | 834.176 | 579.016 | +226.9 % | 15.123.611 |
| BANK OF AMERICA CORP /DE/ | 1.443.313 | 560.391 | +63.5 % | 26.167.264 |
| BlackRock, Inc. | 11.699.870 | 509.032 | +4.5 % | 212.118.644 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.000.000 | -4.172.000 | -80.7 % | 18.130.000 |
| Siren, L.L.C. | 2.229.125 | -1.273.816 | -36.4 % | 40.414.036 |
| Vivo Capital, LLC | 1.557.466 | -1.057.494 | -40.4 % | 28.236.859 |
| CITADEL ADVISORS LLC | 201.144 | -970.480 | -82.8 % | 3.646.741 |
| Saturn V Capital Management LP | 966.609 | -822.007 | -46.0 % | 17.524.621 |
| FCPM III SERVICES B.V. | 4.644.386 | -818.460 | -15.0 % | 84.202.718 |
| MILLENNIUM MANAGEMENT LLC | 158.548 | -745.841 | -82.5 % | 2.874.475 |
| Deep Track Capital, LP | 2.000.000 | -650.000 | -24.5 % | 36.260.000 |
| Sofinnova Investments, Inc. | 1.633.897 | -620.264 | -27.5 % | 29.622.553 |
| MARSHALL WACE, LLP | 83.147 | -593.832 | -87.7 % | 1.507.455 |
Zusätzlich aktuell von 123 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 28.07.2026 | BlackRock, Inc. | Passiv (13G/A) | 7,00 % | 11.489.504 | +1,20 pp | |
| 15.05.2026 | T. Rowe Price Investment Management, Inc. | Passiv (13G/A) | 18,70 % | 30.785.801 | +2,50 pp | |
| 15.05.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 8,30 % | 13.647.376 | -0,20 pp | |
| 06.05.2026 | Abigail P. Johnson (+1) | Passiv (13G) | 5,40 % | 8.908.980 | +0,80 pp | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -6,83 pp | |
| 06.03.2026 | T. Rowe Price Investment Management, Inc. | Passiv (13G/A) | 16,20 % | 26.578.437 | +5,50 pp | |
| 17.02.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 8,50 % | 13.887.722 | -1,90 pp | |
| 08.01.2026 | T. Rowe Price Investment Management, Inc. | Passiv (13G) | 10,70 % | 17.540.089 | Neu | |
| 14.11.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,40 % | 14.745.505 | +0,30 pp | |
| 14.11.2025 | RA Capital Healthcare Fund, L.P. (+3) | Passiv (13G/A) | Ausstieg | 0 | -8,50 pp | |
| 13.11.2025 | Atlas Venture Associates Opportunity I, L.P. (+2) | Passiv (13G/A) | 1,00 % | 1.458.568 | -0,50 pp | |
| 13.11.2025 | Atlas Venture Associates Opportunity II, LLC (+2) | Passiv (13G/A) | 1,40 % | 1.958.427 | Neu | |
| 13.11.2025 | Atlas Venture Associates XI, L.P. (+1) | Passiv (13G/A) | 4,00 % | 5.713.470 | -1,70 pp | |
| 13.11.2025 | Atlas Venture Fund XI, L.P. | Passiv (13G/A) | 4,00 % | 5.697.508 | -1,70 pp | |
| 07.08.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,10 % | 14.394.999 | +0,90 pp | |
| 15.05.2025 | RA Capital Healthcare Fund, L.P. (+3) | Passiv (13G/A) | 8,50 % | 9.714.392 | +2,10 pp | |
| 15.05.2025 | Forbion Growth Opportunities Fund II Cooperatief U.A. (+1) | Passiv (13G/A) | 1,30 % | 1.426.370 | Neu | |
| 15.05.2025 | ForDyne B.V. | Passiv (13G/A) | 4,80 % | 5.400.545 | Neu | |
| 15.05.2025 | Forbion Capital Fund IV Cooperatief U.A. (+1) | Passiv (13G/A) | 3,60 % | 4.036.476 | Neu | |
| 15.05.2025 | Roderick Wong, M.D. (+1) | Passiv (13G/A) | 1,50 % | 1.690.567 | -3,60 pp | |
| 15.05.2025 | Point72 Asset Management, L.P. (+2) | Passiv (13G/A) | 1,50 % | 1.669.342 | -3,60 pp | |
| 14.05.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 9,20 % | 10.353.875 | +1,90 pp | |
| 12.05.2025 | Abigail P. Johnson (+1) | Passiv (13G/A) | 4,60 % | 5.195.294 | -3,30 pp | |
| 17.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 5,80 % | 6.577.879 | Neu | |
| 14.02.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 7,30 % | 7.379.309 | Neu | |
| 14.02.2025 | Roderick Wong, M.D. (+1) | Passiv (13G/A) | 5,10 % | 5.218.641 | -1,70 pp | |
| 12.02.2025 | Abigail P. Johnson (+1) | Passiv (13G/A) | 7,90 % | 7.996.931 | Neu | |
| 03.02.2025 | Point72 Asset Management, L.P. (+2) | Passiv (13G) | 5,10 % | 5.196.597 | Neu | |
| 14.11.2024 | Janus Henderson Group plc | Passiv (13G) | 6,80 % | 6.813.163 | Neu | |
| 14.11.2024 | Deep Track Biotechnology Master Fund, Ltd. (+2) | Passiv (13G/A) | 3,27 % | 3.282.000 | +0,01 pp | |
| 14.11.2024 | RA Capital Healthcare Fund, L.P. (+3) | Passiv (13G/A) | 6,40 % | 6.381.144 | 0,00 pp | |
| 14.11.2024 | Atlas Venture Associates Opportunity I, L.P. (+2) | Passiv (13G/A) | 1,50 % | 1.458.691 | -0,50 pp | |
| 14.11.2024 | Atlas Venture Fund XI, L.P. | Passiv (13G/A) | 5,70 % | 5.698.091 | -3,30 pp | |
| 14.11.2024 | Atlas Venture Associates Opportunity II, (+2) | Passiv (13G/A) | 0,80 % | 847.388 | -0,40 pp | |
| 14.11.2024 | Atlas Venture Associates XI, L.P. (+1) | Passiv (13G/A) | 5,70 % | 5.714.057 | -3,40 pp | |
| 14.11.2024 | Citadel Advisors Holdings LP (+2) | Passiv (13G/A) | 2,90 % | 6 | -2,10 pp | |
| 14.11.2024 | Kenneth Griffin | Passiv (13G/A) | 3,00 % | 6 | -2,70 pp | |
| 14.11.2024 | Citadel Securities Group LP (+2) | Passiv (13G/A) | 0,00 % | 6 | 0,00 pp | |
| 14.11.2024 | Roderick Wong, M.D. (+1) | Passiv (13G) | 6,80 % | 6.818.641 | Neu | |
| 12.11.2024 | The Vanguard Group | Passiv (13G/A) | 6,83 % | 6.864.137 | 0,00 pp |
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | -120.854.000 $ | -0,73 $ | 1.079.950.000 $ | 865.055.000 $ |
| 2025-12-31 | 10-K | – | -446.214.000 $ | -3,47 $ | 1.186.958.000 $ | 972.129.000 $ |
| 2025-09-30 | 10-Q | – | -108.041.000 $ | -0,76 $ | 867.059.000 $ | 691.783.000 $ |
| 2025-06-30 | 10-Q | – | -110.857.000 $ | -0,97 $ | 728.992.000 $ | 571.445.000 $ |
| 2025-03-31 | 10-Q | – | -115.361.000 $ | -1,05 $ | 721.074.000 $ | 668.973.000 $ |
| 2024-12-31 | 10-K | – | -317.418.000 $ | -3,37 $ | 691.234.000 $ | 629.838.000 $ |
| 2024-09-30 | 10-Q | – | -97.125.000 $ | -0,96 $ | 768.844.000 $ | 705.540.000 $ |
| 2024-06-30 | 10-Q | – | -65.102.000 $ | -0,70 $ | 825.884.000 $ | 775.193.000 $ |
| 2024-03-31 | 10-Q | – | -65.649.000 $ | -0,81 $ | 522.279.000 $ | 478.055.000 $ |
| 2023-12-31 | 10-K | – | -235.937.000 $ | -3,95 $ | 165.082.000 $ | 91.292.000 $ |
| 2023-09-30 | 10-Q | – | -60.210.000 $ | -0,99 $ | 205.244.000 $ | 152.038.000 $ |
| 2023-06-30 | 10-Q | – | -64.902.000 $ | -1,08 $ | 251.421.000 $ | 206.877.000 $ |
| 2023-03-31 | 10-Q | – | -44.187.000 $ | -0,78 $ | 288.642.000 $ | 241.935.000 $ |
| 2022-12-31 | 10-K | – | -168.099.000 $ | -3,23 $ | 306.325.000 $ | 252.364.000 $ |
| 2022-09-30 | 10-Q | – | -41.385.000 $ | -0,80 $ | 299.679.000 $ | 249.744.000 $ |
| 2022-06-30 | 10-Q | – | -52.304.000 $ | -1,01 $ | 340.026.000 $ | 287.059.000 $ |
| 2022-03-31 | 10-Q | – | -35.583.000 $ | -0,69 $ | 387.762.000 $ | 336.459.000 $ |
| 2021-12-31 | 10-K | – | -149.291.000 $ | -2,93 $ | 425.663.000 $ | 368.197.000 $ |
| 2021-09-30 | 10-Q | – | -42.582.000 $ | -0,83 $ | 466.878.000 $ | 414.116.000 $ |
| 2021-06-30 | 10-Q | – | -29.955.000 $ | -0,58 $ | 467.147.000 $ | 452.596.000 $ |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 11.05.2026 | – | -0,73 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | – | -0,76 |
| Q2 2025 | 30.06.2025 | 28.07.2025 | – | -0,97 |
| Q1 2025 | 31.03.2025 | 08.05.2025 | – | -1,05 |
| Q3 2024 | 30.09.2024 | 12.11.2024 | – | -0,96 |
| Q2 2024 | 30.06.2024 | 12.08.2024 | – | -0,70 |
| Q1 2024 | 31.03.2024 | 02.05.2024 | – | -0,81 |
| Q3 2023 | 30.09.2023 | 30.10.2023 | – | -0,99 |
| Q2 2023 | 30.06.2023 | 03.08.2023 | – | -1,08 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 11.05.2026 | 10-Q | 31.03.2026 | 41 Tage | SEC » |
| 02.03.2026 | 10-K | 31.12.2025 | 61 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 28.07.2025 | 10-Q | 30.06.2025 | 28 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 27.02.2025 | 10-K | 31.12.2024 | 58 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
| 12.08.2024 | 10-Q | 30.06.2024 | 43 Tage | SEC » |
| 02.05.2024 | 10-Q | 31.03.2024 | 32 Tage | SEC » |
| 05.03.2024 | 10-K | 31.12.2023 | 65 Tage | SEC » |
| 30.10.2023 | 10-Q | 30.09.2023 | 30 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 11.05.2023 | 10-Q | 31.03.2023 | 41 Tage | SEC » |
| 02.03.2023 | 10-K | 31.12.2022 | 61 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 02.05.2022 | 10-Q | 31.03.2022 | 32 Tage | SEC » |
| 10.03.2022 | 10-K | 31.12.2021 | 69 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 04.03.2021 | 10-K | 31.12.2020 | 63 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 22.07.2026 | Kapitalerhöhung | $375,2 Mio · $20,50/Aktie | SEC » |
| 21.07.2026 | Kapitalerhöhung | $300,0 Mio | SEC » |
| 10.12.2025 | Kapitalerhöhung | $350,0 Mio · $18,44/Aktie | SEC » |
| 08.12.2025 | Kapitalerhöhung | $300,0 Mio | SEC » |
| 01.07.2025 | Kapitalerhöhung | $200,0 Mio · $8,25/Aktie | SEC » |
| 30.06.2025 | Kapitalerhöhung | $200,0 Mio | SEC » |
| 12.11.2024 | Kapitalerhöhung | $300,0 Mio | SEC » |
| 22.05.2024 | Kapitalerhöhung | $291,4 Mio · $31,00/Aktie | SEC » |
| 20.05.2024 | Kapitalerhöhung | $300,0 Mio | SEC » |
| 05.01.2024 | Kapitalerhöhung | $300,1 Mio · $17,50/Aktie | SEC » |
| 03.01.2024 | Kapitalerhöhung | $175,0 Mio | SEC » |
| 21.01.2021 | Börsengang | $157,9 Mio · $28,00/Aktie | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 23.04.2026 | HV-Einladung | — | — | DEFA14A | SEC » |
| 23.04.2026 | HV-Einladung | 05.06.2026 Jahres-HV | 07.04.2026 | DEF 14A | SEC » |
| 09.04.2026 | Vorläufig | — | — | PRE 14A | SEC » |
| 15.04.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 15.04.2025 | HV-Einladung | 30.05.2025 Jahres-HV | 04.04.2025 | DEF 14A | SEC » |
| 05.04.2024 | HV-Einladung | — | — | DEFA14A | SEC » |
| 05.04.2024 | HV-Einladung | 22.05.2024 Jahres-HV | 28.03.2024 | DEF 14A | SEC » |
| 07.04.2023 | HV-Einladung | — | — | DEFA14A | SEC » |
| 07.04.2023 | HV-Einladung | 24.05.2023 Jahres-HV | 31.03.2023 | DEF 14A | SEC » |
| 22.04.2022 | HV-Einladung | — | — | DEFA14A | SEC » |
| 22.04.2022 | HV-Einladung | 03.06.2022 Jahres-HV | 08.04.2022 | DEF 14A | SEC » |
| 14.04.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 14.04.2021 | HV-Einladung | 26.05.2021 Jahres-HV | 01.04.2021 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (22.06.2026)
HOCH Abgang Schlüsselpersonen (22.06.2026)
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 22.06.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 23.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 25.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.03.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 29.07.2026 | Quartalszahlen | 0,00 | 40 | Dyne Therapeutics kündigte die Finanzergebnisse für Q2 2026 (Quartal endend 30. Juni 2026) an. Detaillierte Ergebnisse sind im Press Release… 🔒 | SEC |
| 20.07.2026 | Sonstiges | 0,30 | 50 | Dyne Therapeutics, Inc. meldet, dass die FDA den BLA für zeleciment rostudirsen (z-rostudirsen) zur Behandlung von Duchenne-Muskulardystroph… 🔒 | SEC |
| 22.06.2026 | Personalwechsel | 0,10 | 45 | Barry E. Greene wurde von der Board als Class I Director gewählt und wird bis zur jährlichen Hauptversammlung 2027 im Amt sein. | SEC |
| 17.06.2026 | Finanzierung/Anleihe | 0,00 | 45 | Dyne Therapeutics gibt Ergänzungen zu bestehender Kreditfazilität bekannt. Die Änderungen am Darlehensvertrag wurden in mehreren Schritten d… 🔒 | SEC |
| 08.06.2026 | HV-Abstimmung | 0,00 | 20 | Dyne Therapeutics hielt am 5. Juni 2026 ihre Jahreshauptversammlung ab und wählte David Lubner, Brian Posner und Jason Rhodes als Direktoren… 🔒 | SEC |
| 03.06.2026 | Guidance-Update | 0,65 | 70 | Dyne Therapeutics verkündete die vollständige Patientenrekrutierung (71 Teilnehmer) für die Phase-1/2-ACHIEVE-Studie mit zeleciment basivars… 🔒 | SEC |
| 11.05.2026 | Quartalszahlen | 0,00 | 55 | Dyne Therapeutics veröffentlichte Quartalsergebnisse für Q1 2026 (Quartal endend 31. März 2026) in einer Pressemitteilung. | SEC |
| 02.03.2026 | Quartalszahlen | 0,00 | 65 | Dyne Therapeutics kündigt die Finanzergebnisse für das Geschäftsjahr 2025 an. | SEC |
| 12.01.2026 | Quartalszahlen | 0,20 | 40 | Dyne Therapeutics meldet, dass es zum 31. Dezember 2025 voraussichtlich etwa $1,1 Milliarden in Barmitteln, Bargeld-Äquivalenten und handelb… 🔒 | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-30 | 162 | 21,26 | 3.444 |
| 2026-06-22 | 263.431 | 19,80 | 5.215.934 |
| 2026-06-12 | 2.829 | 17,95 | 50.781 |
| 2026-06-10 | 71 | 17,92 | 1.272 |
| 2026-06-08 | 36.267 | 17,04 | 617.990 |
| 2026-06-03 | 1.353 | 17,24 | 23.326 |
| 2026-06-01 | 96 | 19,33 | 1.856 |
| 2026-05-26 | 2 | 17,37 | 35 |
| 2026-05-20 | 8.179 | 15,92 | 130.210 |
| 2026-05-12 | 3.497 | 18,46 | 64.555 |
| 2026-05-11 | 1 | 17,61 | 18 |
| 2026-05-07 | 5 | 18,84 | 94 |
| 2026-04-22 | 2.264 | 19,21 | 43.491 |
| 2026-04-20 | 41.278 | 20,41 | 842.484 |
| 2026-04-02 | 3.836 | 18,10 | 69.432 |
| 2026-03-27 | 14.086 | 18,55 | 261.295 |
| 2026-03-25 | 51.519 | 17,85 | 919.614 |
| 2026-03-12 | 848 | 19,99 | 16.952 |
| 2026-03-11 | 285.203 | 19,78 | 5.641.315 |
| 2026-03-06 | 53.575 | 15,20 | 814.340 |
| 2026-03-04 | 255 | 14,60 | 3.723 |
| 2026-02-13 | 28 | 16,00 | 448 |
| 2026-02-12 | 1.105 | 16,68 | 18.431 |
| 2026-02-11 | 295 | 17,14 | 5.056 |
| 2026-02-04 | 12.549 | 18,96 | 237.929 |